Mário Cirio Nogueira

Dr. Mário Cirio Nogueira


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in The Lancet Global Health
Verified
Journal Article
Open access
IDIsabel Dos-Santos-Silva
Isabel Dos-Santos-Silva
BSBianca L De Stavola
Bianca L De Stavola
NRNelson L Renna
Nelson L Renna
MNMário Cirio Nogueira
Mário Cirio Nogueira
EAEstela M L Aquino
Estela M L Aquino
GSGulnar Azevedo e Silva
Gulnar Azevedo e Silva
Policies for early detection of breast cancer, including clinical breast examinations and mammographic screening, were introduced in Brazil in 2004, but their effect on disease stage at diagnosis is unclear. We aimed to assess whether these policies have led to a decrease in the prevalence of late-stage breast cancer at diagnosis. In this case only analysis, using an anonymised nationwide hospital based-cancer registry network, we identified women aged 18-89 years who had been diagnosed with an invasive breast cancer in Brazil during 2001-14. We extracted individual patient-level data on patient demographics, tumour variables, and health-care provider variables for the centre where the patient was diagnosed. Our objectives were to estimate the prevalence of late-stage breast cancer (TNM stage III or IV) at diagnosis overall, across age groups, and by ethnoracial and social strata (ie, self-reported ethnoracial group, as white, black, brown, Asian, or Indigenous, and educational level, marital status, and region of residence) across the study period, and compare these estimates with international data from high-income countries (Norway and the USA). We used logistic regression to estimate odds ratios (ORs) for late-stage versus early-stage (TNM stage I or II) breast cancer at diagnosis in relation to relevant exposures, either minimally adjusted (for age, year of diagnosis, and region of residence) or fully adjusted (for all patient, tumour, and health-care provider variables). We identified 247 719 women who were diagnosed with invasive breast cancer between Jan 1, 2001, and Dec 31, 2014, with a mean age at diagnosis of 55·4 years (SD 13·3), of whom 36·2% (n=89 550) identified as white, 29·8% (n=73 826) as black or brown, and 0·7% (n=1639) as Asian or Indigenous. Prevalence of late-stage breast cancer at diagnosis remained high throughout 2001-14, at approximately 40%, was inversely associated with educational level (p value for linear trend <0·0001), and was higher for women who identified as black (minimally adjusted OR 1·61, 95% CI 1·53-1·70; fully adjusted OR 1·45, 95% CI 1·38-1·54) and brown (minimally adjusted OR 1·26, 95% CI 1·22-1·30; fully adjusted OR 1·18, 1·14-1·23) than those who identified as white. The predicted prevalence of late-stage cancer at diagnosis was highest for women who were black or brown with little or no formal education (48·8%, 95% CI 48·2-49·5) and lowest for women who were white with university education (29·4%, 28·2-30·6), but both these prevalences were higher than that of all women diagnosed with breast cancer in Norway before the introduction of mammography screening (ie, 16·3%, 95% CI 15·4%-17·2% in 1970-74). Similar ethnoracial and social patterns emerged in analyses restricted to the age group targeted by screening (50-69 years). The persistently high prevalence of late-stage breast cancer at diagnosis across all ethnoracial and social strata in Brazil, although more substantially among the most disadvantaged populations, implies that early detection policies might have had little effect on breast cancer mortality so far, and highlights the need to focus primarily on timely diagnosis of symptomatic breast cancer rather than on screening for asymptomatic disease. Newton Fund, Research Councils UK, and Conselho Nacional das Fundações Estaduais de Amparo à Pesquisa.

1 June 2022 in Ciencia & Saude Coletiva
Verified
Journal Article
Open access
MFMárcia de Castro Martins Ferreira
Márcia de Castro Martins Ferreira
MNMário Cirio Nogueira
Mário Cirio Nogueira
LFLetícia de Castro Martins Ferreira
Letícia de Castro Martins Ferreira
MBMaria Teresa Bustamante-Teixeira
Maria Teresa Bustamante-Teixeira
Resumo O estudo objetivou investigar conhecimentos, atitudes e práticas de profissionais da Estratégia Saúde da Família (ESF) sobre o controle do câncer do colo do útero (CCU) recomendadas pelo Ministério da Saúde (MS). Trata-se de estudo transversal, que utilizou questionário autoaplicável junto aos médicos e enfermeiros da ESF de Juiz de Fora, Minas Gerais, em 2019. Para a análise, empregou-se os testes qui-quadrado e exato de Fisher, nível de significância 5%. Entre os 170 pesquisados, o que correspondeu a 93% dos profissionais da ESF no município, a prevalência de conhecimento adequado foi de 39,4% e teve associação com idade mais jovem e sexo feminino. A prevalência de atitude adequada foi de 59.5%, e de práticas adequadas 77,6%, ambos associados a maior tempo de graduação. A presença das diretrizes do MS nas unidades associou-se aos desfechos conhecimento e prática adequada, ratificando a importância de material de apoio para consulta dos profissionais. Apenas 28,2% dos profissionais relataram ter recebido capacitação nos últimos três anos e 50,3% realizaram ações educativas para as usuárias. Destaca-se necessidade de ações de educação permanente junto aos profissionais, visando uma atuação mais efetiva para o enfrentamento e erradicação do CCU.

24 September 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LFLetícia de Castro Martins Ferreira
Letícia de Castro Martins Ferreira
MNMário Cirio Nogueira
Mário Cirio Nogueira
RPRicardo Vela de Britto Pereira
Ricardo Vela de Britto Pereira
WCWilliam Cossich
William Cossich
MRMoreno Magalhaes de Souza Rodrigues
Moreno Magalhaes de Souza Rodrigues
MCMarilia Sá Carvalho
Marilia Sá Carvalho
Ambient temperature may lead to decompensation of cardiovascular diseases and deaths by acute myocardial infarction (AMI). Little is known about this relationship in South American countries located in regions of a hot climate. This study aims to investigate the effects of ambient temperature on mortality due to AMI in six Brazilian micro-regions, which present different climates. We analyzed daily records of deaths by AMI between 1996 and 2013. We estimated the accumulate relative and attributable risks with lags of up to 14 days, using distributed non-linear lag model. Micro-regions that were closest to the equator did not show an association between temperature and mortality. The lowest risk temperatures varied between 22 °C and 28 °C, in the Southern region of Brazil and the Midwest region, respectively. Low temperatures associated with the highest mortality risk were observed in the same areas, varying between 5 °C and 15 °C. The number of deaths attributed to cold temperatures varied from 176/year in Brasilia to 661/year in São Paulo and those deaths attributed to hot temperatures in Rio de Janeiro amounted to 115/year. We showed the relative risk and the attributable risk of warmer and colder days in tropical regions. The estimate of the number of deaths due to climate, varying according to each area, is a way of bringing information to those responsible for health policies based on easily-understood measurements.

1 January 2019 in Cadernos de Saude Publica
Verified
Journal Article
Open access
PDF file
MNMário Cirio Nogueira
Mário Cirio Nogueira
VFVívian Assis Fayer
Vívian Assis Fayer
CCCamila Soares Lima Corrêa
Camila Soares Lima Corrêa
MGMaximiliano Guerra
Maximiliano Guerra
BSBianca De Stavola
Bianca De Stavola
GSGulnar Azevedo e Silva
Gulnar Azevedo e Silva
Our objectives with this study were to describe the spatial distribution of mammographic screening coverage across small geographical areas (micro-regions) in Brazil, and to analyze whether the observed differences were associated with spatial inequities in socioeconomic conditions, provision of health care, and healthcare services utilization. We performed an area-based ecological study on mammographic screening coverage in the period of 2010-2011 regarding socioeconomic and healthcare variables. The units of analysis were the 438 health micro-regions in Brazil. Spatial regression models were used to study these relationships. There was marked variability in mammographic coverage across micro-regions (median = 21.6%; interquartile range: 8.1%-37.9%). Multivariable analyses identified high household income inequality, low number of radiologists/100,000 inhabitants, low number of mammography machines/10,000 inhabitants, and low number of mammograms performed by each machine as independent correlates of poor mammographic coverage at the micro-region level. There was evidence of strong spatial dependence of these associations, with changes in one micro-region affecting neighboring micro-regions, and also of geographical heterogeneities. There were substantial inequities in access to mammographic screening across micro-regions in Brazil, in 2010-2011, with coverage being higher in those with smaller wealth inequities and better access to health care.

1 January 2023 in Epidemiologia e Serviços de Saúde
Verified
Journal Article
Open access
PDF file
MNMário Cirio Nogueira
Mário Cirio Nogueira
AAAdriana Tavares de Moraes Atty
Adriana Tavares de Moraes Atty
JTJeane Tomazelli
Jeane Tomazelli
BJBeatriz Cordeiro Jardim
Beatriz Cordeiro Jardim
MBMaria Teresa Bustamante-Teixeira
Maria Teresa Bustamante-Teixeira
GSGulnar Azevedo e Silva
Gulnar Azevedo e Silva
Objective: to analyze treatment delay and the flow of care for women with breast cancer in Brazil in 2019 and 2020. Method: this was a follow-up study of breast cancer cases available from the Oncology Panel; a chi-square test and multilevel logistic regression were performed in order to analyze the explanatory variables associated with delay (greater than 60 days) in starting treatment. Results: 22,956 cases (54.5%) with delay in treatment were identified in 2019 and 17,722 (48.7%) in 2020; the Southeast region (54.6%) had the greatest proportion of delay; delay was greater when treatment was provided outside the municipality of residence and lower in 2020 compared to 2019; most outward flows were to the capital cities in the same Federative Units of residence. Conclusion: strategies to reduce cancer treatment delay and optimize health care networks in the Federative Units should be prioritized.

6 September 2018 in Cadernos de Saude Publica
Verified
Journal Article
Open access
PDF file
MNMário Cirio Nogueira
Mário Cirio Nogueira
MGMaximiliano Ribeiro Guerra
Maximiliano Ribeiro Guerra
JCJane Rocha Duarte Cintra
Jane Rocha Duarte Cintra
CCCamila Soares Lima Corrêa
Camila Soares Lima Corrêa
VFVívian Assis Fayer
Vívian Assis Fayer
MBMaria Teresa Bustamante-Teixeira
Maria Teresa Bustamante-Teixeira
Os objetivos foram investigar a associação entre raça/cor e a sobrevivência em 10 anos de mulheres com câncer de mama e o papel do estadiamento como mediador. Coorte hospitalar com 481 mulheres com câncer invasivo de mama, diagnosticadas entre 2003 e 2005. Foram feitas comparações entre mulheres brancas e negras quanto às características sociodemográficas e ao estadiamento, usando o teste qui-quadrado, e à sobrevivência em 10 anos, usando os métodos de Kaplan-Meier e regressão de Cox. Foram estimados para a variável raça/cor efeitos diretos e indiretos, mediados pelo estadiamento, com ajuste para a condição social da área de residência e idade, utilizando o modelo de respostas potenciais (contrafactual) e regressão múltipla de Cox. As mulheres negras residiam em setores censitários de menor renda, eram usuárias do setor público em maior proporção e foram diagnosticadas com estadiamentos mais avançados. A sobrevivência específica em 10 anos foi de 64,3% (IC95%: 60,0; 68,9), com diferença significativa entre brancas (69,5%; IC95%: 64,8; 74,6) e negras (44%; IC95%: 35,2; 55,1). Nos modelos múltiplos, ajustados para renda e idade, as negras tiveram pior prognóstico (HR = 2,09; IC95%: 1,76; 2,51), e a proporção mediada pelo estadiamento foi de 40% (IC95%: 37; 42). Há disparidade racial na sobrevivência do câncer de mama em 10 anos, mediada principalmente pelo estadiamento mais avançado da doença nas mulheres negras. Isso aponta para a necessidade de ampliar a cobertura e a qualidade do programa de rastreamento dessa doença e facilitar o acesso ao diagnóstico e tratamento precoces, com vistas à redução da iniquidade racial.